Treatment of Recurrent Soft Tissue Sarcoma For information about the treatments listed below, see Treatment Option Overview
36687-82-8, with high quality and used in food, cosmetics, and dietary supplements
Recalls & Warnings September 19, 2018 FDA Warns Seller of Shilajit On September 6, 2018, the FDA issued a warning letter to Adaptive Energy LLC, following an inspection of the company's website, which found statements made about its shilajit product, Purblack were found to be drug claims
Since this complication lacks effective treatments, we aimed to evaluate the effectiveness of L-carnitine supplementation in reducing the frequency, duration, and severity of muscle cramps in patients with liver cirrhosis